Diabetes Research and Clinical Practice
Volume 65, Issue 2 , Pages 135-142 , August 2004

Variability in the presence of the metabolic syndrome in Type 2 diabetic patients attending a diabetes clinic: Influences of age and gender

,Revised 29 September 2003 ,Accepted 9 December 2003.

References 

  1. Alberti KGMM, Zimmet PZ  for the WHO consultation . Definition, diagnosis and classification of Diabetes Mellitus and its complications. Part 1. Diagnosis and classification of Diabetes Mellitus, provisional report of a WHO consultation. Diabet. Med. 1999;15:539–553
  2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA 285 (2001) 2486–2497.
  3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA. 2002;287:356–359
  4. Barrett-Connor E, Grundy SM, Holdbrook JJ. Plasma lipids and diabetes mellitus in an adult community. Am. J. Epidemiol. 1982;115:657–663
  5. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ. Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am. J. Epidemiol. 1984;120:834–851
  6. Sniderman AD, Lamarche B, Tilley J, Seccombe D, Frohlich J. Hypertriglyceridemic hyperapoB in Type 2 diabetes. Diabetes Care. 2002;25:579–582
  7. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: the Strong Heart Study. Diabetes Care. 1998;21:1258–1265
  8. Goldschmid MG, Barrett-Connor E, Edelstein SL, Wingard DL, Cohn BA, Herman WH. Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. Circulation. 1994;89:991–997
  9. Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 1972;18:499–502
  10. Balkau B, Charles MA  for the European Group for the Study of Insulin Resistance (EGIR) . Comment on the provisional report from the WHO consultation. Diabet. Med. 1999;16:442–443
  11. Groop L, Ekstrand A, Forsblom C, Widen E, Groop PH, Teppo AM. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1993;36:642–647
  12. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure, Arch. Intern. Med. 157 (1997) 2413–2446.
  13. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of Hypertension: Guidelines Subcommittee, J. Hypertens. 17 (1999) 151–183.
  14. Lakka HM, Laaksonen DE, Lakka TA, et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–2716
  15. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353:89–92
  16. Rossouw JE. Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovasc. Res. 2002;53:550–557
  17. Mendelsohn ME, Karas RH. Mechanisms of disease: the protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 1999;340:1801–1811
  18. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N. Engl. J. Med. 1987;316:1105–1110
  19. Seeman T, Mendes de Leon E, Berkman L, Ostfeld A. Risk factors for coronary heart disease among older men and women: a prospective study of community-dwelling elderly. Am. J. Epidemiol. 1993;138:1037–1049

PII: S0168-8227(03)00334-6

doi: 10.1016/j.diabres.2003.12.003

Diabetes Research and Clinical Practice
Volume 65, Issue 2 , Pages 135-142 , August 2004

Article Tools